Cite

HARVARD Citation

    Bergmann, L. et al. (n.d.). A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer. European journal of cancer. 51 (1), pp. 27-36. [Online]. 
  
Back to record